Liver Failure – Pipeline Insight, 2018 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Liver
Failure – Pipeline Insight, 2018”
drug pipelines has been added
to ResearchAndMarkets.com’s offering.

This report offers a comprehensive insight of the pipeline (under
development) therapeutics scenario and growth prospects across Liver
Failure development.
The report provides detailed coverage of the pipeline landscape for this
mechanism of action, equipped with data from multiple sources with
complete pipeline analysis by developmental stage, associated
indications, route of administration and molecule type.

Scope

  • The report provides a snapshot of the pipeline development for Liver
    Failure
  • The report covers pipeline activity across the complete product
    development cycle i.e. clinical, pre-clinical and discovery stages for
    Liver Failure
  • The report provides pipeline product profiles which includes product
    description, developmental activities, licensors & collaborators and
    chemical information
  • Provides pipeline assessment by monotherapy and combination therapy
    products, stage of development, route of administration, and molecule
    type for Liver Failure
  • The report also covers the dormant and discontinued pipeline projects
    related to Liver Failure
Companies Featured

  • Alfact Innovation
  • BioLineRx Ltd.
  • Cell2B Advanced Therapeutics SA
  • Immune Pharmaceuticals Inc.
  • Mina Therapeutics Ltd.
  • Mylan NV
  • Ocera Therapeutics Inc.
  • PledPharma AB
  • Promethera Biosciences SA

Key Topics Covered

1. Report Introduction

2. Liver Failure Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Liver Failure

4. Comparative Analysis

5. Products in Clinical Stage

5.1 Drug Name: Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

6.1 Drug Name: Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

8.1 Drug Name: Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/jt5bxp/liver_failure?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Liver
and Kidney Disorders Drugs